Neoantigen Cancer Vaccines

Neoantigens are the most common antigen used in cancer vaccines, with 169 of the current 1200+ cancer vaccines utilizing them. This shows a promising area in therapeutic research therefore, we have created an infographic providing you with an overview of neoantigen cancer vaccines.

Discover the breakdown of all the 169 different cancer vaccine assets by downloading the infographic.

Neoantigen Cancer Vaccines Infographic

This infographic covers

  • Number of assets in each trial phase and, the typical pattern that emerges when looking at the highest phase of development
  • Clinical growth through the distribution of the number of trials over time
  • Trials that have been withdrawn since 2011 with reasoning

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search